Submissions

Login or Register to make a submission.

Author Guidelines

Welcome to the RevisX author submission portal. These guidelines will help you prepare and submit your manuscript for consideration. Please read through all sections carefully before submitting your work. You can download the guidelines file here.

Before You Submit

Before submitting your manuscript, please confirm the following:

  • Scope alignment: Your work fits within the journal's aims and scope. Review our scope to confirm RevisX is the right journal for your research.
  • Authorship criteria: All listed authors meet the ICMJE authorship standards (substantial contributions to conception/design, data acquisition/analysis, drafting/revising the work, final approval, and accountability).
  • Originality: The manuscript has not been published elsewhere and is not currently under consideration by another journal.
 

Ethical Requirements

RevisX adheres to strict ethical standards for all published research. For comprehensive details, please review our Editorial Policies.

Human Subjects Research

Studies involving human participants must have approval from an appropriate institutional review board (IRB) or ethics committee. Authors must confirm that informed consent was obtained from all participants and that patient confidentiality has been protected. For case reports, written informed consent for publication must be obtained from patients or their legal guardians.

Animal Studies

Research involving animals must comply with institutional and national guidelines for the care and use of laboratory animals. Authors should provide details of the ethical approval and describe measures taken to minimize animal suffering.

Clinical Trials

Clinical trials must be registered in a publicly accessible database (e.g., ClinicalTrials.gov) before patient enrollment begins. The trial registration number should be included at the end of the abstract.

 

Manuscript Preparation

File Format and Language

Manuscripts should be submitted in Microsoft Word format (.doc or .docx). All submissions must be written in clear, grammatically correct English. Authors for whom English is not their first language may wish to have their manuscript professionally edited before submission.

Formatting

Use the following formatting throughout your manuscript:

  • Font: Times New Roman, 12 pt
  • Line spacing: Double-spaced throughout
  • Margins: 2.5 cm (1 inch) on all sides
  • Page numbering: Number all pages consecutively
  • Line numbering: Enable continuous line numbering (aids peer review)

Title Page

The title page should include:

  • Article title (concise and informative, avoid abbreviations)
  • Full names and affiliations of all authors
  • Corresponding author's contact information (email, phone, postal address)
  • Word count (excluding abstract, references, and figure legends)
  • Number of figures and tables

Abstract

Original Research Articles: Use a structured abstract (250-300 words) with the following headings: Background, Methods, Results, and Conclusions.

Review Articles: Provide an unstructured abstract (200-250 words) summarizing the main themes and conclusions.

Case Reports: Use a structured abstract with headings: Introduction, Case Presentation, and Conclusion (150-200 words).

Keywords

Provide 4-6 keywords below the abstract. Use terms from the Medical Subject Headings (MeSH) database where possible to improve discoverability.

Main Body Structure

Original Research Articles should follow the IMRaD format:

  • Introduction: State the research question and objectives clearly
  • Methods: Describe the study design, participants, procedures, and statistical analyses in sufficient detail to allow replication
  • Results: Present findings logically, using tables and figures to support the text
  • Discussion: Interpret the results, acknowledge limitations, and suggest future directions

Review Articles should include an Introduction, thematic sections organized by subtopic, and a Conclusion.

Case Reports should include: Introduction, Case Presentation (including patient history, examination, diagnosis, treatment, and outcome), Discussion, and Conclusion.

For additional content types, please refer to our Content Types page.

Figures and Tables

Figures and tables should be cited in the text in numerical order and should be self-explanatory:

  • Figures: Submit as separate high-resolution files (minimum 300 dpi, TIFF, JPEG, or PNG format). Include concise captions below each figure.
  • Tables: Create using Word's table function (not as images). Number consecutively and provide a descriptive title above each table.
  • Ensure all abbreviations used in figures and tables are defined in the caption or footnote.

Supplementary Materials

Authors may submit supplementary materials (e.g., datasets, extended methods, additional figures) that will be published online alongside the article. Ensure supplementary files are clearly labeled and cited in the main manuscript.

 

Referencing

RevisX uses APA 7th edition style for all references. Cite references in the text by author and year (e.g., Smith, 2023 or Smith & Jones, 2023). List all references alphabetically at the end of the manuscript.

Common Reference Examples

Journal Article:

Smith, J. A., & Johnson, B. C. (2023). Advances in gene therapy for rare diseases. Journal of Medical Research, 45(3), 123-145. https://doi.org/10.1234/jmr.2023.45.3.123

Book:

Brown, L. M. (2022). Principles of immunology (3rd ed.). Academic Press.

Website:

World Health Organization. (2023, January 15). Global health statistics. https://www.who.int/data/global-health-statistics

For comprehensive APA formatting guidance, consult the official APA Style Guide.

 

Submission Process

Follow these steps to submit your manuscript through our online portal:

  1. Create an account: Visit the submission portal and register using your email address.
  2. Start a new submission: Log in and click "Submit New Manuscript" to begin the submission process.
  3. Select article type: Choose the appropriate content type for your manuscript (e.g., Original Research, Review, Case Report).
  4. Enter manuscript details: Provide the title, abstract, keywords, and author information as prompted.
  5. Upload files: Upload your manuscript file, figures (as separate files), and any supplementary materials. Include a cover letter addressing the editor.
  6. Add co-authors: Enter the names and email addresses of all co-authors. They will receive notification of the submission.
  7. Review and submit: Carefully review all entered information and uploaded files before clicking "Submit."
  8. Confirmation: You will receive an email confirmation with a manuscript tracking number. Use this number to check your submission status.

If you encounter any technical issues during submission, please contact our editorial office.

 

Peer Review Process

RevisX employs a rigorous double-blind peer review process to ensure the quality and integrity of published research. Here's what to expect:

Review Stages

  1. Editorial screening (3-5 days): The Editor-in-Chief or a Senior Editor assesses whether the manuscript fits the journal's scope and meets basic quality standards.
  2. Peer review (4-6 weeks): If the manuscript passes initial screening, it is sent to at least two independent reviewers with expertise in the relevant field.
  3. Editorial decision (1-2 weeks after reviews received): The editor evaluates reviewer comments and makes a decision.

Possible Outcomes

  • Accept: The manuscript is accepted without further changes.
  • Minor revision: Small changes are required; typically reviewed by the editor only.
  • Major revision: Substantial revisions needed; manuscript returns to reviewers after revision.
  • Reject: The manuscript is not suitable for publication in RevisX.

Authors will receive detailed reviewer comments along with the editorial decision. Transparency and constructive feedback are central to our review process.

 

Article Processing Charges (APCs)

RevisX operates as an open-access journal, ensuring that published research is freely available to readers worldwide. To support this model, we charge article processing fees for accepted manuscripts.

Fee Structure

  • Standard APC: $65 USD
  • Fees are charged only after manuscript acceptance, not at submission.

Waivers and Discounts

RevisX offers APC waivers or discounts on a case-by-case basis for authors from low-income countries or those facing genuine financial hardship. To request a waiver, please submit a brief statement explaining your circumstances in your cover letter at the time of submission. All waiver requests are reviewed confidentially by the editorial board.

 

After Acceptance

Once your manuscript is accepted, the following steps will occur:

Proof Review

Authors will receive a typeset proof of the article for review. At this stage, only minor corrections (e.g., typos, formatting errors) are permitted. Substantial changes to content cannot be accommodated during proofing. Authors typically have 72-96 hours to return corrected proofs.

Publication Timeline

After proof approval and APC payment, articles are published online within 2-3 weeks.

Open Access License

All articles published in RevisX are licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing unrestricted use, distribution, and reproduction in any medium, provided proper attribution is given.

 

Policies

RevisX is committed to maintaining the highest standards of research integrity and ethical publishing. For comprehensive policy details, please review our Editorial Policies page. Key policies include:

Plagiarism and Originality

All submissions are screened for plagiarism using detection software. Manuscripts with substantial overlap with published work (including author's own previous publications) will be rejected. Proper citation of all sources is mandatory.

Conflicts of Interest

All authors must disclose any financial, professional, or personal relationships that could be perceived as influencing their research. If no conflicts exist, this should be explicitly stated in the manuscript.

Data Availability

Authors are encouraged to make the data underlying their research publicly available in an appropriate repository. Data availability statements should be included in the manuscript, specifying where and how data can be accessed.

Corrections and Retractions

If significant errors are identified post-publication, the journal will issue corrections, errata, or, in cases of serious misconduct or fundamental flaws, retractions in accordance with COPE guidelines.

Use of AI in Manuscript Preparation

Authors may use AI tools for language editing, grammar checking, or literature searching. However, AI cannot be listed as an author, and any use of AI in manuscript preparation must be disclosed in the methods or acknowledgments section. Authors remain fully responsible for the content and accuracy of their work.

Submission Preparation Checklist

All submissions must meet the following requirements.

  • This submission meets the requirements outlined in the Author Guidelines.
  • This submission has not been previously published, nor is it before another journal for consideration.
  • All references have been checked for accuracy and completeness.
  • All tables and figures have been numbered and labeled.
  • Permission has been obtained to publish all photos, datasets and other material provided with this submission.

Articles

Full-length original research papers presenting comprehensive studies with significant findings. Articles are the primary vehicle for publishing novel research at RevisX.

Format:

  • Up to 5,000 words (excluding abstract, Methods, references, and figure legends)
  • Abstract: up to 300 words, unstructured
  • Up to 8 figures and/or tables
  • Up to 60 references
  • Supplementary: Permitted; linked online
  • Peer reviewed: Yes — double-blind
When to choose this type

Choose this type for complete, multi-experiment studies that present substantial new findings requiring full exposition of methods, results, and discussion. Articles are the primary vehicle for publishing novel research at RevisX and are suitable when your findings cannot be adequately presented in a shorter format.

Article structure
  • Introduction (no heading) — establish context, knowledge gap, and study aims
  • Results — organised by topical subheadings; present data without interpretation
  • Discussion (no subheadings) — interpret findings, discuss limitations, and future directions
  • Online Methods — organised by topical subheadings; full reproducible methodological detail
  • References
  • Figure legends (not counted toward word limit)
  • Supplementary information (optional, linked online)
Peer review

Full double-blind peer review by a minimum of two independent expert reviewers. Authors receive structured review reports and have the opportunity to revise and respond.

Submission process

Submit via the RevisX online submission portal. Prepare a cover letter outlining the significance of your findings and confirming the work has not been published or submitted elsewhere. All co-authors must approve the final submission.

Note: Data availability and ethics statements are mandatory. All primary data must be deposited in an appropriate public repository prior to acceptance.

Review

Comprehensive, authoritative overviews of specific topics written by leading experts. Reviews synthesize current understanding and provide new conceptual frameworks.

Format:

  • • Up to 4,000 words (excluding abstract and references)
  • • Up to 6 figures and/or tables
  • • Up to 150 references
  • • Peer reviewed: Yes
When to choose this type

Reviews are appropriate when a topic has accumulated sufficient primary literature to warrant synthesis and critical evaluation. They should not merely summarise existing work but provide a new conceptual framework, resolve apparent contradictions, or clearly define open questions. Reviews are often solicited by editors but unsolicited proposals are considered.

Article structure
  • Abstract — concise summary of the scope and key conclusions
  • Introduction — establish the importance of the topic and the review's scope
  • Thematic sections with subheadings — logically organised coverage of the field
  • Conclusions and outlook — synthesise key messages and identify future research directions
  • References
  • Boxes (optional) — for definitions, case studies, or key concepts
Peer review

Peer reviewed by subject-matter experts. Reviews are assessed for balance, accuracy, and whether they advance understanding beyond existing literature.

Submission process

Authors are encouraged to contact the editors with a proposal (title, outline, author list) before preparing a full manuscript. Full submissions are accepted but proposals help avoid duplication with in-preparation commissioned reviews.

Note: Authors should declare any conflicts of interest, particularly if they have primary research publications in the area being reviewed.

Case Report

Case Reports describe unique, rare, or educationally valuable clinical or experimental cases that contribute meaningful insights to scientific or medical understanding. They may highlight unusual presentations, novel diagnostic approaches, innovative treatments, or unexpected outcomes that advance knowledge in the field.

Submissions should present a clear and well-documented narrative including background, case description, diagnostic assessments, management or intervention, and discussion of clinical relevance. The report must emphasize the learning value, originality, and implications for future research or practice.

Manuscripts are typically concise, generally 1,500–2,500 words, and may include up to two figures or tables. Authors must obtain informed consent from the patient (or legal guardian) prior to publication and ensure that identifying information is fully anonymized. Ethical approval is required when applicable.

All Case Reports are subject to editorial evaluation and may undergo peer review. Acceptance is based on the case’s novelty, clarity, and educational significance. The journal adheres to COPE and ICMJE guidelines to ensure ethical publication practices.

Case Series

Reports describing a group of patients with similar diagnoses, treatments, or outcomes, providing observational evidence and identifying clinical patterns.

Format:

  • Up to 3,000 words (excluding abstract and references)
  • Abstract: up to 250 words, structured
  • Up to 6 figures and/or tables
  • Up to 30 references
  • Supplementary: Permitted
  • Peer reviewed: Yes
When to choose this type

Case Series are appropriate when multiple patients share a notable clinical pattern that warrants systematic description — a cluster of rare presentations, a cohort treated with a novel intervention, or a group illustrating the spectrum of a condition. They provide stronger observational evidence than individual case reports and can generate hypotheses for future controlled studies.

Article structure
  • Abstract — structured summary (Background, Methods, Results, Conclusions)
  • Introduction — clinical context and rationale for the series
  • Methods — patient selection criteria, data collection, and ethical approvals
  • Results — demographic and clinical data presented systematically, often in tabular form
  • Discussion — patterns identified, comparison with literature, limitations, and clinical implications
  • Conclusions — summary of findings and implications for practice or research
  • References
Peer review

Peer reviewed. Reviewers evaluate the rigor of case selection, consistency of data presentation, and the validity of conclusions drawn from the observational evidence.

Submission process

Submit via the RevisX online submission portal. Include details of ethics approval and patient consent procedures in your cover letter. Clearly state the inclusion criteria and time period for the series.

 

Note: Ethics approval or institutional review board approval is required. Patient consent for publication must be obtained for all individuals in the series. Aggregate or de-identified data presentation is expected unless explicit consent for identifiable information has been provided.

Editorial

Editorial

Journal position statements and commentary on research policy, ethics, and practice. Editorials represent the voice of RevisX on matters important to the research community.

When to choose this type

Editorials represent the voice of RevisX on matters important to the research community — policy developments, ethical standards, publishing practices, and responses to major events. Most are written by RevisX editors. On significant occasions, the journal invites a leading expert to contribute an Editorial representing an authoritative external perspective. Invited Editorials are clearly labelled as such.

Article structure
  • No formal sections — written as authoritative, concise essay
  • Clear opening statement of the issue or position
  • Development of the argument or stance
  • Concluding statement or call to action
Peer review

Internal editorial review. Invited Editorials are reviewed by a senior RevisX editor for accuracy, tone, and alignment with journal standards before publication.

Submission process

Not open for unsolicited submission. Researchers who wish to be considered as an invited Editorial contributor may contact the editors. The final decision on invitation rests with the editorial team.

Words: Up to 1,200
Figures: None
References: Not required 
Review: Internal
Internal or by invitation only

Copyright Notice

Website Content

Unless otherwise stated, website content, branding, logos, and platform materials are the property of RevisX and may not be reproduced or distributed without permission.

 

Published Articles

Copyright and licensing of published articles are governed by the license selected for each article and displayed on the article page.

 

Author rights

Authors retain the rights specified in the publication agreement and applicable article license.

 

Permitted Uses

Readers may access, download, and share articles in accordance with the applicable license terms.

 

Requests

For copyright, permissions, or reuse requests, contact: contact@revisx.com

 

Copyright Infringement

If you believe content on RevisX infringes your copyright, please contact us with sufficient details so that we may investigate and respond appropriately.

Privacy Statement

RevisX respects your privacy and is committed to protecting your personal information.

Information We Collect

  • Account information (name, email address, affiliation).
  • Manuscript submission and review information.
  • Communications sent to us.
  • Usage data and analytics collected through cookies and similar technologies.

How We Use Your Information

  • Operate and maintain our website and services.
  • Improve our website and user experience.
  • Communicate with you about your account or submissions.
  • Conduct research and analysis to enhance our offerings.
  • Maintain website security and integrity.

Information Sharing

We do not sell personal information. Information may be shared with service providers or partners who help us operate the journal, subject to appropriate safeguards.


Data Security

We implement reasonable technical and organizational measures to protect personal information. However, no method of electronic transmission or storage is completely secure.


Your rights

Depending on your location, you may have rights to access, correct, update, or delete your personal information.


Contact Us

For privacy-related inquiries, contact: contact@revisx.com

RevisX